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Abstract We have used NMR spectroscopy to monitor the 
phosphorylation of a peptide corresponding to the N-terminal 
region of human cardiac troponin-I (residues 17-30), encompass- 
ing the two adjacent serine residues of the dual phosphorylation 
site. An ordered incorporation of phosphate catalysed by PKA 
was observed, with phosphorylation of Ser-24 preceding that of 
Ser-23. Diphosphorylation i duced a conformational transition in 
this region, involving the specific association of the Arg-22 and 
Ser-24P side-chains, and maximally stabilised when both 
phosphoserines were in the di-anionic form. The results suggest 
that the second phosphorylation at Ser-23 of cardiac troponin-I 
is of particular significance in the mechanism by which adrenaline 
regulates the calcium sensitivity of the myofibrillar actomyosin 
Mg-ATPase. 
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1. Introduction 
of human cardiac troponin-I, and investigated the localised 
structural consequences of multiple phosphorylation. 
2. Materials and methods 
The peptide (APIRRRSSNYRAYA), corresponding toresidues 17- 
30 of the human cardiac troponin-I sequence, was obtained from Alta 
Bioscience, University of Birmingham. Its molecular weight and com- 
position were verified by mass spectrometry and amino acid analysis. 
The peptide and its phosphorylated derivates were purified by HPLC, 
using a Vydac C18 column and a water/acetonitrile gradient. Phospho- 
rylation was carried out with bovine heart PKA (Sigma, Poole, UK) 
at 27°C in the presence of 50 mM Tris, 1 mM MgC12, 1 mM cAMP and 
5 mM ATP in HzO or 2H20, pH 7.6. For gel analysis, samples were 
removed at intervals and electrophoresed through 15% Acrylogel 5 gels 
(BDH, Poole, UK) in the presence of 5% acetic acid, 6 M urea. Gels 
were fixed with 1.5% perchloric acid, stained with Coomassie blue 
R250, and immediately photographed as the bands faded rapidly. 
NMR experiments were performed using a Bruker AMX500 spectro- 
meter. Standard pulse sequences were used for 2D ~H homonuclear 
TOCSY and NOESY experiments. Water suppression was achieved by 
presaturation during the relaxation delay or by the Watergate gradient 
pulse scheme [7]. 
The phosphorylation f troponin-I that follows treatment of 
heart muscle with adrenaline reduces the sensitivity of the tro- 
ponin-regulated cardiac actomyosin ATPase activity to calcium 
[1,2]. This effect is associated with the incorporation of up to 
2 moles of phosphate at a PKA target site in the tissue-specific 
N-terminal region of troponin-I [3]. The target comprises adja- 
cent serines [4]; residues 23 and 24 in the case of the human 
sequence [5]. The correlation between contractile response and 
the state of phosphorylation of these two serine residues is, 
however, currently ill-defined, and little is known about the 
structural basis of regulation by this dual-site phosphorylation. 
Phosphorylation f both serine residues in vivo is considered 
to be catalysed by a single enzyme. As in the case of the insulin 
receptor protein-tyrosine kinase [6], this suggests ome flexibil- 
ity of the kinase active site to allow phosphorylation of both 
basal and monophosphorylated substrates. The target sequence 
(-IRRRSSNYR-) does not conform exactly to the consensus, 
single-site, recognition sequence of PKA, in which the site of 
phosphotransfer (P) is immediately preceded by a small residue 
(position P- l )  and followed by a hydrophobic residue (P+I). 
We therefore undertook the real-time NMR study of the phos- 
phorylation profile of a peptide encompassing residues 17-30 
*Corresponding author. Fax: (44) (121) 414-3982. 
3. Results 
3.1. Ordered phosphorylation of the adjacent serine residues 
Phosphorylation of the cardiac troponin-I peptide by PKA 
could be readily monitored on acid gels due to the altered 
mobility of the phosphorylated species with increasing negative 
charge. Conversion of the peptide to a monophosphorylated 
form and subsequent diphosphorylation are illustrated in Fig. 
1. As this procedure could not identify the serine residue(s) 
modified in the monophosphorylated species, we used IH NMR 
spectroscopy to visualise the phosphorylation profile in real 
time and identify the phosphorylated serine(s) at each stage. 
Two distinct sets of spectral changes were apparent during 
the phosphorylation time-course (Fig. 2), indicating that phos- 
phate incorporation occurred in successive stages. The first 
stage of phosphorylation was associated with alterations in the 
resonances of Ser-24 and Tyr-26, while the signals of Ser-23 
remained unperturbed (Figs. 2 and 3). HPLC analysis of phos- 
phorylation reactions halted at this stage revealed only a single 
major species, indentified by 2D NMR methods as peptide 
monophosphorylated on Ser-24 (Fig. 3). Thus, the initial phos- 
phorylation occurred exclusively on Ser-24, and reached > 90% 
completion before the second stage began. Peptide mono- 
phosphorylated on Ser-23 was never seen. 
The second stage of phosphorylation was characterised by 
shifts in the resonances of Ser-23 and Asn-25 (Figs. 2 and 3), 
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Fig. 1. Timecourse of troponin-I peptide phosphorylation monitored 
by acid gel electrophoresis. Conditions were as described in section 2. 
Samples (tracks 1-7) were taken 0, 5, 15, 30, 60, 90 and 120 min, 
respectively, after addition of PKA. 
while the signals of Ser-24P were relatively unperturbed. HPLC 
analysis revealed amajor species, deduced from its NMR spec- 
trum to be phosphorylated on both Ser-23 and Ser-24, along 
with small amounts (< 10%) of the Ser-24-monophosphorylated 
peptide. This stage was 3-4 times slower than the first, and 
clearly represented the further phosphorylation at Ser-23 of the 
Ser-24-monophosphorylated troponin-I peptide. 
3.2. Conformational consequences of sequential phosphorylation 
To confirm the identity of the phosphorylated serine residues 
at each stage of the phosphorylation process and to investigate 
any resulting conformational effects, 2D 1H homonuclear 
NOESY studies of the isolated peptides were undertaken. The 
fingerprint (backbone-NH/C~H) regions of the spectra of the 
basal and monophosphorylated species are compared in Fig. 
3, along with the corresponding 2D IH TOCSY spectra. The 
downfield shift of the Ser-24-NH and C~H2 proton resonances 
identify it unequivocally as the residue modified upon mono- 
phosphorylation, anassignment also supported by the spectral 
changes hown by these resonances when the solution pH was 
titrated through the pK a of the phosphate group (data not 
shown). Interestingly, the C6H 2 (Fig. 2) and side-chain -NH 
protons of Arg-22 (visualised in H20, pH 5.7: data not shown) 
were both shifted downfield in the monophosphorylated spe- 
cies, the latter by around 0.3 ppm. This suggested a specific 
interaction between this arginine side-chain and the phosphate 
group of Ser-24P. Further evidence for a structural adjustment 
and restriction of the conformational veraging of the sequence 
around Ser-24 upon monophosphorylation was obtained from 
the increased number and strength of through-space (NOE) 
interactions (Figs. 3 and 4). The extent and intensity of NOE 
interactions were further increased upon diphosphorylation 
(Fig. 4), indicating that the adjacent phosphorylated residues 
imposed further conformational restrictions on the surround- 
ing sequence. 
To investigate the contribution of the charge of the phos- 
phate groups to this structural stabilisation, NOESY spectra of 
the diphosphorylated peptide were obtained at pH 5.6 and pH 
7.0. Despite an overall reduction in NOE intensities in the 
fingerprint region at the higher pH (resulting from increased 
-NH exchange rates with the H20 protons), a further group of 
NOE cross-peaks became apparent at pH 7.0, most notably 
those between Arg-22 and Ser-24P (Fig. 4). These cross-peaks 
were not present in a NOESY spectrum of the mono- 
phosphorylated peptide at pH 7.0 (data not shown). Stabilisa- 
tion of the association between the Arg-22 and Ser-24P side- 
chains is thus favoured when the phosphate groups are in the 
di-anionic form. 
4. Discussion 
When isolated from perfused heart, troponin-I contains 
about 1 tool phosphate/tool protein, located mainly at its N- 
terminal region, which increases to 2 tool/tool after intervention 
with adrenaline [3]. Associated with the increased phosphoryla- 
tion is a fall in the calcium sensitivity of the myofibrillar acto- 
myosin Mg-ATPase. Although the order of phosphorylation f 
the N-terminal site in vivo remains undetermined, our results 
suggest that phosphorylation f Ser-24 precedes that of Ser-23. 
The PKA consensus for the P + 1 and P-1 positions is matched 
more closely by the Ser/Asn flanking Ser-24 than by the 
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Fig. 2. Time course of troponin-I peptide phosphorylation monitored 
by 1H NMR spectroscopy. Spectra (A-D) were summed from 32 tran- 
sients (total acquisition time 1.5 min), obtained immediately before, 
then 15, 34 and 120 min after initiation of phosphorylation. 
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Fig. 3.2D IH homonuclear NMR spectra of basal and Ser-24P-monophosphorylated troponin-I peptide. (A) basal peptide TOCSY; (B) basal peptide 
NOESY; (C) Ser-24P peptide TOCSY; (D) Ser-24P peptide NOESY. TOCSY spectra were acquired in 90% H20, pH 5.6, at 12°C with a mixing 
time of 60 ms. NOESY spectra were acquired under identical conditions, with a mixing time of 600 ms. 
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Arg/Ser around Ser-23. In particular, the preference for a small 
residue at P-1 is consistent with the docking mode of the inhib- 
itor peptide, PKI, to PKA, in which this side-chain estles 
against he nucleotide-binding, glycine-rich loop [9]. This ana- 
lysis suggests that the main N-terminal residue phosphorylated 
in the normal perfused heart would be Ser-24, with the decrease 
in calcium sensitivity following adrenaline intervention arising 
from the subsequent phosphorylation of Ser-23. However, 
while it is widely accepted that PKA catalyses the phosphoryl- 
ation of both N-terminal serines in vivo, the fact that phospho- 
rylation of troponin-I occurs while it is part of the troponin 
complex may allow steric influences to cause deviation from 
this pattern. Endogenous phosphatase activity may also come 
into play. For example, if both Ser-23 and Ser-24-mono- 
phosphorylated substrates were available in vivo, our analysis 
¢e-- 
Fig. 4. Partial inter-residue NOE maps of basal, monophosphorylated 
and diphosphorylated troponin-I peptides. Strong, medium and weak 
negative NOE cross-peaks are indicated by l ,  m,  and m,  respec- 
tively. NOE peaks observed at pH 7.0 but not at pH 5.6 are indicated 
by • o. N = backbone-NH; cc= -C~H; SC = side-chain (all other 
protons). The NOE interaction between -C~H of $23P and -NH of $24P 
in the diphosphorylated peptide could not be assigned unambiguously 
due to spectral overlap. 
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predicts that further phosphorylation of the Ser-24P species 
would be favoured, given the bulky, di-anionic nature of the 
P-1 position for the Ser-23P species. 
Diphosphorylation of the cardiac troponin-I peptide is 
shown to result in a well-defined organisation about the dual 
phosphorylation site, involving the stabilisation of a specific 
interaction between Arg-22 and Ser-24P. Such a change in vivo 
may cause the loosening of any association of the N-terminal 
region of troponin-I with other proteins within the cardiac thin 
filament assembly, and/or the cooperative modification of 
other troponin-I contacts. This may explain the observations 
that diphosphorylation f troponin-I causes a reduction in af- 
finity and cooperatively in its binding to F-actin [8], and a 
decrease in its affinity for troponin-C [10]. 
Diphosphorylation may mediate the regulation of acto- 
myosin ATPase activity in smooth muscle, where ATPase activ- 
ity is increased upon phosphorylation of myosin regulatory 
light chain at Ser-19 and further enhanced by additional phos- 
phorylation at Thr-18 [11]. Mutation of both Ser-19 and Thr-18 
to Asp gave only partial ATPase activation [11]. This may be 
explained by the single negative charge of the aspartate side- 
chain being less effective than the doubly-charged phosphate; 
in the cardiac troponin-I system, the conformational transition 
observed upon diphosphorylation was more effectively stabi- 
lised by doubly-charged phosphates. The region of the myosin 
regulatory light chain preceding the dual phosphorylation site, 
Arg-13 Arg-16, is required for the phosphorylation mediated 
regulation. The role of these basic residues may be to interact 
PG. Quirk et aI. IFEBS Letters 370 (1995) 175 178 
with the nearby phosphorylated si e-chains in a similar manner 
to the Arg-22/Ser-24P interaction of troponin-I. 
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